145 related articles for article (PubMed ID: 38127922)
1. A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses.
Simmons HC; Watanabe A; Oguin Iii TH; Van Itallie ES; Wiehe KJ; Sempowski GD; Kuraoka M; Kelsoe G; McCarthy KR
PLoS Biol; 2023 Dec; 21(12):e3002415. PubMed ID: 38127922
[TBL] [Abstract][Full Text] [Related]
2. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
[TBL] [Abstract][Full Text] [Related]
3. Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
Allen JD; Ross TM
J Virol; 2022 Apr; 96(7):e0165221. PubMed ID: 35289635
[TBL] [Abstract][Full Text] [Related]
4. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
[TBL] [Abstract][Full Text] [Related]
5. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
Zost SJ; Parkhouse K; Gumina ME; Kim K; Diaz Perez S; Wilson PC; Treanor JJ; Sant AJ; Cobey S; Hensley SE
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12578-12583. PubMed ID: 29109276
[TBL] [Abstract][Full Text] [Related]
6. Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain.
Raymond DD; Stewart SM; Lee J; Ferdman J; Bajic G; Do KT; Ernandes MJ; Suphaphiphat P; Settembre EC; Dormitzer PR; Del Giudice G; Finco O; Kang TH; Ippolito GC; Georgiou G; Kepler TB; Haynes BF; Moody MA; Liao HX; Schmidt AG; Harrison SC
Nat Med; 2016 Dec; 22(12):1465-1469. PubMed ID: 27820604
[TBL] [Abstract][Full Text] [Related]
7. Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
Wang W; Alvarado-Facundo E; Vassell R; Collins L; Colombo RE; Ganesan A; Geaney C; Hrncir D; Lalani T; Markelz AE; Maves RC; McClenathan B; Mende K; Richard SA; Schofield C; Seshadri S; Spooner C; Utz GC; Warkentien TE; Levine M; Coles CL; Burgess TH; Eichelberger M; Weiss CD
Clin Infect Dis; 2021 Dec; 73(11):e4312-e4320. PubMed ID: 32898271
[TBL] [Abstract][Full Text] [Related]
8. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.
Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q
J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468
[TBL] [Abstract][Full Text] [Related]
9. Anamnestic broadly reactive antibodies induced by H7N9 virus more efficiently bind to seasonal H3N2 strains.
Chen Y; Hilchey SP; Wang J; Garigen J; Zand MS; Huang J
Hum Vaccin Immunother; 2022 Nov; 18(6):2128014. PubMed ID: 36197079
[TBL] [Abstract][Full Text] [Related]
10. Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody.
Raymond DD; Bajic G; Ferdman J; Suphaphiphat P; Settembre EC; Moody MA; Schmidt AG; Harrison SC
Proc Natl Acad Sci U S A; 2018 Jan; 115(1):168-173. PubMed ID: 29255041
[TBL] [Abstract][Full Text] [Related]
11. Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates.
Darricarrère N; Qiu Y; Kanekiyo M; Creanga A; Gillespie RA; Moin SM; Saleh J; Sancho J; Chou TH; Zhou Y; Zhang R; Dai S; Moody A; Saunders KO; Crank MC; Mascola JR; Graham BS; Wei CJ; Nabel GJ
Sci Transl Med; 2021 Mar; 13(583):. PubMed ID: 33658355
[TBL] [Abstract][Full Text] [Related]
12. Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans.
Zost SJ; Lee J; Gumina ME; Parkhouse K; Henry C; Wu NC; Lee CD; Wilson IA; Wilson PC; Bloom JD; Hensley SE
Cell Rep; 2019 Dec; 29(13):4460-4470.e8. PubMed ID: 31875553
[TBL] [Abstract][Full Text] [Related]
13. Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions.
Mittal N; Sengupta N; Malladi SK; Reddy P; Bhat M; Rajmani RS; Sedeyn K; Saelens X; Dutta S; Varadarajan R
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578291
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses.
Allen JD; Ross TM
Front Immunol; 2021; 12():707339. PubMed ID: 34475872
[TBL] [Abstract][Full Text] [Related]
15. First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes.
Guthmiller JJ; Han J; Li L; Freyn AW; Liu STH; Stovicek O; Stamper CT; Dugan HL; Tepora ME; Utset HA; Bitar DJ; Hamel NJ; Changrob S; Zheng NY; Huang M; Krammer F; Nachbagauer R; Palese P; Ward AB; Wilson PC
Sci Transl Med; 2021 Jun; 13(596):. PubMed ID: 34078743
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation.
Gouma S; Furey C; Santos JJS; Parkhouse K; Weirick M; Muramatsu H; Pardi N; Fan SHY; Weissman D; Hensley SE
J Virol; 2023 Jan; 97(1):e0172322. PubMed ID: 36533954
[TBL] [Abstract][Full Text] [Related]
17. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.
Wang S; Taaffe J; Parker C; Solórzano A; Cao H; García-Sastre A; Lu S
J Virol; 2006 Dec; 80(23):11628-37. PubMed ID: 16987975
[TBL] [Abstract][Full Text] [Related]
18. Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
Allen JD; Ray S; Ross TM
PLoS One; 2018; 13(9):e0204284. PubMed ID: 30265682
[TBL] [Abstract][Full Text] [Related]
19. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.
Matrosovich MN; Gambaryan AS; Teneberg S; Piskarev VE; Yamnikova SS; Lvov DK; Robertson JS; Karlsson KA
Virology; 1997 Jun; 233(1):224-34. PubMed ID: 9201232
[TBL] [Abstract][Full Text] [Related]
20. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine.
Wu NC; Zost SJ; Thompson AJ; Oyen D; Nycholat CM; McBride R; Paulson JC; Hensley SE; Wilson IA
PLoS Pathog; 2017 Oct; 13(10):e1006682. PubMed ID: 29059230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]